A comparison of latanoprost, bimatoprost, and travoprost in patients with elevated intraocular pressure: a 12-week, randomized, masked-evaluator, multicenter study

[...]at the primary end point, the among-group statistic for the per-protocol patient population was significant, and bimatoprost provided a significantly larger mean IOP reduction than travoprost. Tables 3 and 4 of the report summarize ocular adverse events including "ocular hyperemia/red eye....

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	American journal of ophthalmology 2004-02, Vol.137 (2), p.387-388
1. Verfasser:	Bernstein, Paula
Format:	Artikel
Sprache:	eng
Schlagworte:	Amides Antihypertensive Agents - therapeutic use Bimatoprost Clinical trials Cloprostenol - analogs & derivatives Cloprostenol - therapeutic use Glaucoma Glaucoma, Open-Angle - drug therapy Humans Intraocular Pressure - drug effects Lipids - therapeutic use Multicenter Studies as Topic Ocular Hypertension - drug therapy Prostaglandins F, Synthetic - therapeutic use Randomized Controlled Trials as Topic Statistical methods Travoprost
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	[...]at the primary end point, the among-group statistic for the per-protocol patient population was significant, and bimatoprost provided a significantly larger mean IOP reduction than travoprost. Tables 3 and 4 of the report summarize ocular adverse events including "ocular hyperemia/red eye.Ã¢[euro] Information about this adverse event was elicited from patients, which inflates the number of reports.
ISSN:	0002-9394 1879-1891
DOI:	10.1016/j.ajo.2003.10.043